Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region

Biochemical and Biophysical Research Communications

Volumn 304, Issue 1, 2003, Pages 184-190

  Shiohama, Aiko ^a   Sasaki, Takashi ^a   Noda, Setsuko ^b   Minoshima, Shinsei ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

22q11.2; Conotruncal anomaly face syndrome; DGCR8; DiGeorge syndrome; DiGeorge syndrome chromosomal region; Expression analysis; Gene structure; Genome sequencing; Velocardiofacial syndrome

Indexed keywords

AMINO ACID; PROTEIN; PROTEIN DGCR8; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CHROMOSOME 22Q; CHROMOSOME DELETION; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONOTRUNCAL ANOMALY FACE SYNDROME; CONTROLLED STUDY; DIGEORGE SYNDROME; EMBRYO; EMBRYO DEVELOPMENT; EXON; FACE DISORDER; GENE EXPRESSION; GENE ISOLATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; LIMB BUD; MOLECULAR CLONING; MOUSE; NEUROEPITHELIUM; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; ORTHOLOGY; PALATE; PHENOTYPE; PRIORITY JOURNAL; THYMUS; VELOCARDIOFACIAL SYNDROME;

EID: 0037466486     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00554-0     Document Type: Article

References (35)

1. Wilson D.I., Burn J., Scambler P., Goodship J. DiGeorge syndrome: part of CATCH 22. J. Med. Genet. 30:1993;852-856.
2. DiGeorge A. A new concept of the cellular basis of immunity. J. Pediatr. 67:1965;907-908.
3. Shprintzen R.J., Goldberg R.B., Lewin M.L., Sidoti E.J., Berkman M.D., Argamaso R.V., Young D. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 15:1978;56-62.
4. Goldberg R., Motzkin B., Marion R., Scambler P.J., Shprintzen R.J. Velo-cardio-facial syndrome: a review of 120 patients. Am. J. Med. Genet. 45:1993;313-319.
5. Matsuoka R., Kimura M., Scambler P.J., Morrow B.E., Imamura S., Minoshima S., Shimizu N., Yamagishi H., Joh-O K., Watanabe S., Oyama K., Saji T., Ando M., Takao A., Momma K. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum. Genet. 103:1998;70-80.
6. Shprintzen R.J., Goldberg R., Golding-Kushner K.J., Marion R.W. Late-onset psychosis in the velo-cardio-facial syndrome. Am. J. Med. Genet. 42:1992;141-142.
7. Ryan A.K., Goodship J.A., Wilson D.I., Philip N.et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 34:1997;798-804.
8. Vantrappen G., Devriendt K., Swillen A., Rommel N., Vogels A., Eyskens B., Gewillig M., Feenstra L., Fryns J.P. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet. Couns. 10:1999;3-9.
9. Driscoll D.A., Budarf M.L., Emanuel B.S. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am. J. Hum. Genet. 50:1992;924-933.
10. Tezenas Du Montcel S., Mendizabai H., Ayme S., Levy A., Philip N. Prevalence of 22q11 microdeletion. J. Med. Genet. 33:1996;719.
11. Lindsay E.A., Goldberg R., Jurecic V., Morrow B., Carlson C., Kucherlapati R.S., Shprintzen R.J., Baldini A. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am. J. Med. Genet. 57:1995;514-522.
12. Morrow B., Goldberg R., Carlson C., Das Gupta R., Sirotkin H., Collins J., Dunham I., O'Donnell H., Scambler P., Shprintzen R. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am. J. Hum. Genet. 56:1995;1391-1403.
13. Carlson C., Sirotkin H., Pandita R., Goldberg R.et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am. J. Hum. Genet. 61:1997;620-629.
14. Levy A., Demczuk S., Aurias A., Depetris D., Mattei M.G., Philip N. Interstitial 22q11 microdeletion excluding the ADU breakpoint in a patient with DiGeorge syndrome. Hum. Mol. Genet. 4:1995;2417-2419.
15. Kurahashi H., Nakayama T., Osugi Y., Tsuda E., Masuno M., Imaizumi K., Kamiya T., Sano T., Okada S., Nishisho I. Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region. Am. J. Hum. Genet. 58:1996;1377-1381.
16. Lindsay E.A., Halford S., Wadey R., Scambler P.J., Baldini A. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization. Genomics. 17:1993;403-407.
17. Gong W., Emanuel B.S., Collins J., Kim D.H., Wang Z., Chen F., Zhang G., Roe B., Budarf M.L. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum. Mol. Genet. 5:1996;789-800.
18. Lindsay E.A., Rizzu P., Antonacci R., Jurecic V., Delmas-Mata J., Lee C.C., Kim U.J., Scambler P.J., Baldini A. A transcription map in the CATCH22 critical region: identification, mapping, and ordering of four novel transcripts expressed in heart. Genomics. 32:1996;104-112.
19. Baumer A., Dutly F., Balmer D., Riegel M., Tukel T., Krajewska-Walasek M., Schinzel A.A. High level of unequal meiotic crossovers at the origin of the 22q11.2 and 7q11.23 deletions. Hum. Mol. Genet. 7:1998;887-894.
20. Edelmann L., Pandita R.K., Morrow B.E. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am. J. Hum. Genet. 64:1999;1076-1086.
21. Dunham I., Shimizu N., Roe B.A., Chissoe S.et al. The DNA sequence of human chromosome 22. Nature. 402:1999;489-495.
22. Bonfield J.K., Rada C., Staden R. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res. 26:1998;3404-3409.
23. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. second ed. 1994;129 CSHL Press, Cold Spring Harbor.
24. Takahashi H., Noda S., Imamura Y., Nagasawa A., Kubota R., Mashima Y., Kudoh J., Oguchi Y., Shimizu N. Mouse myocilin (Myoc) gene expression in ocular tissues. Biochem. Biophys. Res. Commun. 248:1998;104-109.
25. St Johnston D., Brown N.H., Gall J.G., Jantsch M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA. 89:1992;10979-10983.
26. Green S.R., Mathews M.B. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6:1992;2478-2490.
27. Bevilacqua P.C., Cech T.R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry. 35:1996;9983-9994.
28. Sudol M., Chen H.I., Bougeret C., Einbond A., Bork P. Characterization of a novel protein-binding module - the WW domain. FEBS Lett. 369:1995;67-71.
29. Einbond A., Sudol M. Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett. 384:1996;1-8.
30. Sudol M., Hunter T. NeW wrinkles for an old domain. Cell. 103:2000;1001-1004.
31. Guris D.L., Fantes J., Tara D., Druker B.J., Imamoto A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet. 27:2001;293-298.
32. Yamagishi H., Garg V., Matsuoka R., Thomas T., Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science. 283:1999;1158-1161.
33. Farrell M.J., Stadt H., Wallis K.T., Scambler P., Hixon R.L., Wolfe R., Leatherbury L., Kirby M.L. HIRA, a DiGeorge syndrome candidate gene, is required for cardiac outflow tract septation. Circ. Res. 84:1999;127-135.
34. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27:2001;286-291.
35. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 410:2001;97-101.